Precision HD trial update
The exciting trials Precision HD 1 and 2, continue to enroll participants. Wave Life Sciences expect to share the first results byRead more.
April Newsletter from EHA
Read all about the HD therapeutic conference in Palm Springs, lates news from Roche, the upcoming EHA conference in BucharestRead more.
Bright Lights Big City: HD-COPE descends upon New York City
The HD-COPE committee held its second annual meeting in the Big Apple, February 21-24, 2019. This year the committee welcomedRead more.
Report from the 14th Huntington’s Disease Therapeutics Conference
This year in February the 14th Huntington’s Disease Therapeutics Conference took place in Palm Springs, USA. This is one ofRead more.
Roche changes plans – Less lumbar punctures needed in HD trial
Roche announced today, March 21st 2019, that the procedures in the huntingtin lowering trial Generation HD will be changed. InsteadRead more.
Apply for The Fellowship Programme in Huntington’s Disease!
The Fellowship Programme in Huntington’s Disease is now open for the 2019 round of applications. Deadline 15 March! Published at ehdn.org EHDNRead more.
It’s Rare Disease Day!
Today is the twelfth international Rare Disease Day coordinated by EURORDIS. This year’s theme is ‘Bridging health and social care’.Read more.
GENERATION HD1: Spain and UK sites announced today!
Today, Roche announced their enrollment of European participants from Spain and UK in GENERATION HD1. Over the next two years,Read more.